Identifying “longevity genes” in humans


Albert Einstein College of Medicine


Nir Barzilai, MD, director of the Institute for Aging Research, director of the Nathan Shock Center of Excellence in the Basic Biology of Aging, professor of medicine and of genetics at Albert Einstein College of Medicine


The identification of longevity genes by Einstein researchers may lead to new drug therapies that could slow aging, which would significantly delay the onset of age-related diseases, such as Alzheimer’s disease, type 2 diabetes and cardiovascular disease. This would lead to fewer years of disability and disease and significantly reduce healthcare spending.